Opportunities in smallcaps header image 2

First Look At Second Sight

March 31st, 2018 · No Comments

  • Speculative company that produces ‘bionic eyes.’
  • It has multiple growth avenues in front of it and much of the hard work is already behind them.
  • However, for investors there remain considerable financial risks.

Source: First Look At Second Sight – Second Sight Medical Products (NASDAQ:EYES) | Seeking Alpha

Tags: EYES